illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Euglena
Company logo

Euglena | Sustainability Performance

https://www.euglena.jp/

Specializes in biotechnology involving algae-based products for health, cosmetics, and sustainable energy.

2005

Japan

501 - 1,000 employees

Biotechnology

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9276
Overall
#389
in Japan
#194
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

229 out of 245

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Rici Healthcare

Japan, Health Care, Hospital & Health Care


Company logo
Santen Pharmaceutical

Japan, Health Care, Pharmaceuticals


Company logo
Takeda Pharmaceutical

Japan, Health Care, Pharmaceuticals

Market cap

47.9B $, 2026▲22.5% YoY

Revenue

50.4B $, 2025▼5.5% YoY

R&D intensity

0% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

47.9B $, 2026▲22.5% YoY

Revenue

50.4B $, FY2025▼5.5% YoY

EBITDA

3.1B $, FY2025▼9.1% YoY

Operating margin

6% Industry: -8722▼89.8% YoY

P/E ratio

-67.8 Industry: 6▲26.4% YoY

Revenue & EBITDA

$50.4BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

4.6B 2025▲9.8% YoY

Capex

595.0M 2025▲23% YoY

Debt/equity ratio

0.9 Industry: 2▼NaN% YoY

R&D intensity

0.0%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-1.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

46.5

▲ 2.5%

2023

47.6

▼ 10.5%

2024

50.4

▲ 3.3%

2025

50.0

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

29%
Independent Directors

4 out of 14 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


Total sustainability employees

4-6


    Available in
    Scale package

    Access
  • Email

  • Email